key: cord-0870066-mluxn4mj
authors: Frankfurter, Claudia; Buchan, Tayler A.; Kobulnik, Jeremy; Lee, Douglas S.; Luk, Adriana; McDonald, Michael; Ross, Heather J.; Alba, Ana C.
title: Reduced rate of hospital presentations for heart failure during the Covid-19 pandemic in Toronto, Canada
date: 2020-07-17
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.07.006
sha: 795ba09b518b74089adf4ba1bc7bf539d62c6865
doc_id: 870066
cord_uid: mluxn4mj

Coronavirus disease 2019 (Covid-19) has resulted in public health measures and healthcare reconfigurations likely to impact chronic disease care. We aimed to assess the volume and characteristics of patients presenting to hospital with acute decompensated heart failure (ADHF) during the 2020 Covid-19 pandemic compared to a time-matched 2019 cohort. Patients presenting to hospital with ADHF from March 1 to April 19, 2020 and 2019 in an urban hospital were examined. Multivariable logistic regression models were used to evaluate the difference in probability of ADHF-related hospitalization between the two years. During the Covid-19 pandemic, a total of 1,106 Emergency Department (ED) visits for dyspnea or peripheral edema were recorded, compared to 800 ED visits in 2019. A decrease in ADHF-related ED visits of 43.5% (14.8-79.4%, p=0.002) and ADHF-related admissions of 39.3% (8.6-78.5%, p=0.009) was observed compared to 2019. Patients presenting to hospital with ADHF (n=128) were similar in age, sex, and co-morbidities, compared to the 2019 cohort (n=186), however a higher proportion had a recent heart failure diagnosis. Upon ED presentation, the relative probability of hospitalization or intensive care admission was not statistically different. There was a trend towards higher in-hospital mortality in 2020. The decline in ADHF-related hospitalizations raises the timely question of how patients with heart failure are managing beyond the acute care setting and reinforces the need for public education on the availability and safety of emergency services throughout the Covid-19 pandemic.

2 Summary: During the Covid-19 pandemic in March-April 2020, a decrease in acute decompensated heart failure-related Emergency Department visits and hospitalizations of 44% and 39%, respectively, was observed compared to a time-matched 2019 cohort. Probability of hospitalization or intensive care admission was not statistically different. There was a trend towards higher in-hospital mortality in 2020. 3 

Coronavirus disease 2019 (Covid-19) has resulted in public health measures and healthcare reconfigurations likely to impact chronic disease care. We aimed to assess the volume and characteristics of patients presenting to hospital with acute decompensated heart failure (ADHF) during the 2020 Covid-19 pandemic compared to a time-matched 2019 cohort. Patients presenting to hospital with ADHF from March 1 to April 19, 2020 and 2019 in an urban hospital were examined. Multivariable logistic regression models were used to evaluate the difference in probability of ADHF-related hospitalization between the two years. During the Covid-19 pandemic, a total of 1,106 Emergency Department (ED) visits for dyspnea or peripheral edema were recorded, compared to 800 ED visits in 2019. A decrease in ADHF-related ED visits of 43.5% (14.8-79.4%, p=0.002) and ADHF-related admissions of 39.3% (8.6-78.5%, p=0.009) was observed compared to 2019. Patients presenting to hospital with ADHF (n=128) were similar in age, sex, and co-morbidities, compared to the 2019 cohort (n=186), however a higher proportion had a recent heart failure diagnosis. Upon ED presentation, the relative probability of hospitalization or intensive care admission was not statistically different. There was a trend towards higher in-hospital mortality in 2020. The decline in ADHF-related hospitalizations raises the timely question of how patients with heart failure are managing beyond the acute care setting and reinforces the need for public education on the availability and safety of emergency services throughout the Covid-19 pandemic. 4 Since December 2019, the severe acute respiratory syndrome coronavirus 2 This study was approved by the Research Ethics Board (#20-5326). Inclusion criteria consisted of adults patients (≥18 years) presenting either to the ED (with a triage diagnosis of "shortness of breath" and/or "leg swelling/edema") or as a direct admission from an ambulatory clinic (with an admitting diagnosis of "heart failure") who had ADHF, defined by (1) a brain natriuretic peptide (BNP) of ≥100pg/mL or (2) left ventricular ejection fraction (LVEF) by echocardiography within 5 the last year or during the index hospitalization of ≤50%, along with (3) clinical records recording a diagnosis of ADHF based on compatible clinical symptoms. Patients were excluded if they had an implantable ventricular assist device/cardiac transplant, high BNP secondary to severe pulmonary disease or ADHF secondary to an acute coronary syndrome (ACS). Informed consent was obtained for patients whose data were collected prospectively from April 10, 2020 onwards; consent was waived for patients included retrospectively.

We screened electronic medical records of all patients presenting to the ED and those directly admitted from ambulatory clinics with the pre-specified triage or admitting diagnosis codes for study eligibility. We extracted clinical and laboratory data from electronic medical records, including demographics, co-morbidities, HF characteristics, physical examination parameters, and laboratory data. Covid-19 status was determined in the 2020 patient cohort according to institutional guidelines using nasopharyngeal swab testing. We collected information on the number of ED visits for patients presenting with dyspnea or peripheral edema and with ADHF specifically. For patients hospitalized with ADHF, data on admission to an intensive care unit and in-hospital mortality was abstracted.

For analysis, we compared characteristics of patients with ADHF seen during the 2020 pandemic to the 2019 time-matched cohort using Wilcoxon rank-sum tests and χ 2 or Fisher's exact tests for continuous and categorical variables, respectively. We used a generalized linear mixed model with random intercepts corrected for time as a weekly variable to estimate the percent change in ED visits of patients complaining with dyspnea or peripheral edema, ED visits for ADHF, and hospitalizations for ADHF during the pandemic and previous year. We used multiple logistic regression models to evaluate whether the odds of hospitalization after presenting to the ED with 6 ADHF differed by timeframe after taking into account patient characteristics. All statistical analyses were performed using Stata 16 (College, Station, Texas, USA).

From March 1 to April 19, 2020, a total of 1,106 ED visits for dyspnea or peripheral 

The demographic characteristics of patients presenting to hospital with ADHF were not significantly different between years. The median population age was 75 years; 161 (51%) patients were female and 81 (26%) had an underlying ischemic cardiomyopathy. A higher 7 proportion of patients presenting in 2020 did, however, have a more recent diagnosis of HF. A comparable proportion of patients were on guideline-directed medical therapy.

By multivariable analysis, odds of hospitalization following ED presentation for ADHF was not 

As a testament to the collateral damage of the Covid-19 pandemic, parallel trends in the volume of patients seeking medical care for non-Covid-19 medical concerns have been witnessed in jurisdictions around the world. In a retrospective analysis of 15 centers in the United States, a 43% reduction in hospitalization rates for acute cardiovascular conditions, including heart failure, acute coronary syndrome, and stroke from January to March 2020 was observed when compared to 2019, mirroring trends in the decline of ACS across the world. 3 In Mississippi, a 50% decline in the number of HF hospitalizations has been noted, mirrored by a likewise dramatic decline in HF hospitalizations in New York City. 4, 5 The observed phenomenon of reduced ADHF-related ED visit and hospitalization volumes is likely secondary to a complex interplay of public health and social factors. It is conceivable that fear of Covid-19 acquisition associated with the medical environment and strict 8 social isolation imperatives may have biased patients with HF to either attempt to self-manage their condition at home and/or defer pursuit of medical care. Conversely, public health measures resulting in limited access to the commercial food industry, increased medication adherence in the absence of otherwise habitual diversions (e.g. work, travel), increased time for leg elevation, and lower total daily energy expenditure may be contributors to lower ADHF Additionally, increased access to medical care via telecommunication may have resulted in more rapidly available follow-up and management obviating the need for ADHF-related admission. pandemic are likely needed.

Our description of the trends in ADHF-related ED volumes and hospitalization rates offers early insight into the indirect effects of the Covid-19 pandemic on patient care. Chronic HF management is likely to be an integral component of the health system's response to the 9 Covid-19 pandemic, both in protecting this vulnerable population from acute and severe decompensations, and in reducing the burden on hospital resources. The precipitous decline observed in ADHF-related ED visits and hospitalizations raises the timely question of how these patients are managing beyond the acute care setting and reinforces the need for broad public education on the continued availability and safety of emergency services throughout the Covid-19 pandemic.

None.

None. Caption: There was an average increase in total ED visits of 38.3% (26.3%-51.6%, p<0.001), average decrease in ADHF-related ED visits of 43.5% (14.8%-79.4%, p=0.002), and average decrease in ADHF-related hospitalizations of 39.3% (8.6%-78.5%, p=0.009) between 2020 and 2019. These changes were more significant following the declaration of a public lockdown in Ontario, with an observed increase in total ED visits of 44.0% (29.4%-60.3%, p<0.001), a decrease in ADHF-related ED visits of 79.2% (34.3%-139.0%, p<0.001), and a decrease in ADHF-related hospitalizations of 64.5% (20.0%-225%, p=0.002).

Legend: ED denotes Emergency Department; HF: heart failure

WHO declares COVID-19 a pandemic

Potential effects of coronaviruses on the cardiovascular system: a review

Declines in hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic: a multicenter tertiary care experience

Reductions in heart failure hospitalizations during the COVID-19 pandemic

Heart failure in the COVID-19 pandemic: where has all New York's congestion gone?